Omnicell, Inc.
NASDAQ:OMCL · NASDAQ Global Select
-$0.58 today
Vol 1.24M · Avg 0.57M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+37.65%
Period High
$51.39
Period Low
$26.88
Latest
$39.05
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
10x Genomics, Inc.
NASDAQ:TXG
$4.46B
Progyny, Inc.
NASDAQ:PGNY
$2.05B
Astrana Health, Inc.
NASDAQ:ASTH
$1.94B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.84B
Teladoc Health, Inc.
NYSE:TDOC
$1.40B
Schrödinger, Inc.
NASDAQ:SDGR
$1.16B
Omada Health
NASDAQ:OMDA
$1.05B
GoodRx Holdings, Inc.
NASDAQ:GDRX
$918.57M
SS Innovations International, Inc.
NASDAQ:SSII
$696.46M
Phreesia, Inc.
NYSE:PHR
$580.72M
What is the latest OMCL filing?
The latest filing shown is SD dated May 29, 2026.
How many recent filings does OMCL have?
Intrinsic Alpha currently shows 20 recent filings for OMCL.
Explore More
Continue the stock analysis
Jump to another research area for this company.